在心力衰竭治疗中应用心:机遇和挑战
Chenlei Zhou1, Yaping Xu2, Zhikun Guo1,2
1Henan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Henan, P.R. China.
International journal of medical sciences
|October 6, 2025
概括
心衍生细胞 (EPDC) 为心力衰竭提供了一个有前途的再生方法,解决目前治疗方法的局限性. 本综述探讨了它们在心脏修复和未来治疗策略中的潜力.
科学领域:
- 再生医学是一种再生医学.
- 心血管生物学 心血管生物学
背景情况:
- 心力衰竭是全球主要的健康负担,治疗选择有限.
- 目前的治疗方法,如药物,器件 (LVAD,ICD) 和移植,具有显著的缺点,包括耐药性,并发症和供体稀缺.
研究的目的:
- 审查心上表皮和心上表皮衍生细胞 (EPDC) 在心脏再生中的作用.
- 评估基于心脏表皮的治疗方法在心力衰竭管理中的应用.
- 讨论这些新策略的翻译潜力和挑战.
主要方法:
- 文献综述侧重于上心脏解剖学,EPDC功能和再生机制.
- 分析当前和新兴的基于表心的治疗方法.
- 对临床翻译障碍和未来方向的评估.
主要成果:
- 副心脏和EPDC在心脏修复和再生中起着至关重要的作用.
- EPDCs可以通过直接细胞疗法,生物材料和基因疗法用于心脏修复.
- 基于心的策略显示出显著的希望,作为传统心力衰竭治疗的替代方案.
结论:
- 基于心细胞的细胞疗法代表了治疗心力衰竭的新且有前途的途径.
- 需要进一步的研究和开发来克服翻译挑战并优化治疗疗效.
- 利用EPDC的再生潜力可以彻底改变心力衰竭的治疗.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Heart Failure IV: Classification and Diagnostic Evaluation
319
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319
Layers of the Heart Wall
5.0K
The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
5.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401


